Alperen Korkmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alperen Korkmaz has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Sunday Azagba
College of Nursing, Pennsylvania State University, University Park, USA
4 shared publications - Todd Ebling
Pennsylvania State University, College of Nursing, University Park, PA, USA
4 shared publications Emilee J. Delbridge
Affiliation Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
1 shared publicationEmily E. Spencer
Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA
1 shared publicationFares Qeadan
Loyola University Parkinson School of Health Sciences and Public Health, Illinois
1 shared publication- Jason C. Massengill
Department of Graduate Medical Education, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA
1 shared publication
Latest Publications
- Open Access
- 8 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0351210
Mediating role of depression medication on association between Body Mass Index and cigarette smoking among US adults: Insights from the NHIS
Depression in people who are obese, and smoke cigarettes is often complicated by the possibility of using smoking as a tool for coping with stress. This study sought to determine the mediating role of depression medication on smoking among obese, overweight, normal weight and underweight adults. Data from the 2023 National Health Interview Survey, an annual public health survey of adults from 18–65 years of age in the United States of America, was analyzed using a Generalized Structural Equation Model. Underweight participants on depression medication were more likely to smoke compared to obese participants (reference group: obese; aOR = 0.49, 95% CI: [0.38, 0.63]). There was an indirect association between obesity and depression medication on smoking and obese participants on depression medication had 1.32 times higher odds of smoking when using depression medication compared to underweight individuals (aOR = 1.32, 95% CI: [1.09, 1.56]). Use of depression medication had the highest mediating role on smoking among underweight and the lowest role among obese participants (aOR = 1.64, 95% CI: [1.05, 2.22]). The findings suggest that body mass index should be considered in planning smoking cessation interventions in health care settings.
- 8 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0351210
Open AccessMediating role of depression medication on association between Body Mass Index and cigarette smoking among US adults: Insights from the NHIS
Depression in people who are obese, and smoke cigarettes is often complicated by the possibility of using smoking as a tool for coping with stress. This study sought to determine the mediating role of depression medication on smoking among obese, overweight, normal weight and underweight adults. Data from the 2023 National Health Interview Survey, an annual public health survey of adults from 18–65 years of age in the United States of America, was analyzed using a Generalized Structural Equation Model. Underweight participants on depression medication were more likely to smoke compared to obese participants (reference group: obese; aOR = 0.49, 95% CI: [0.38, 0.63]). There was an indirect association between obesity and depression medication on smoking and obese participants on depression medication had 1.32 times higher odds of smoking when using depression medication compared to underweight individuals (aOR = 1.32, 95% CI: [1.09, 1.56]). Use of depression medication had the highest mediating role on smoking among underweight and the lowest role among obese participants (aOR = 1.64, 95% CI: [1.05, 2.22]). The findings suggest that body mass index should be considered in planning smoking cessation interventions in health care settings.
- Open Access
- 23 February 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (8) , 1134-1141
Topical Hemostatic Agents and the Risk of Pelvic Infection in Gynecologic Surgery
- 23 February 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (8) , 1134-1141
Open AccessTopical Hemostatic Agents and the Risk of Pelvic Infection in Gynecologic Surgery
- Open Access
- 4 March 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 68 (6) , 1142-1149
State Preemption Repeal: A Pathway to Broader Smoke-Free Indoor Air Policies in the U.S.
- 4 March 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 68 (6) , 1142-1149
Open AccessState Preemption Repeal: A Pathway to Broader Smoke-Free Indoor Air Policies in the U.S.
- 25 June 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 176, 354-359
Social media use and mental health indicators among US adolescents: A population-based study
- 25 June 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 176, 354-359
Social media use and mental health indicators among US adolescents: A population-based study
- 27 April 2024
- Published by Elsevier in Public Health
- Vol. 231, 116-123
The impact of cigarette cost on pack sales per capita consumption in the United States
- 27 April 2024
- Published by Elsevier in Public Health
- Vol. 231, 116-123
The impact of cigarette cost on pack sales per capita consumption in the United States
- 17 April 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 127, 104408
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019
- 17 April 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 127, 104408
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019